Spain· ES:05315001
APTIVUS 250 MG CAPSULAS BLANDAS
A medicinal product containing tipranavir, registered in Spain by Boehringer Ingelheim International Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- tipranavir
- Manufacturer
- Boehringer Ingelheim International Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tipranavir in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAptivus 250 mgBoehringer Ingelheim International
- CzechiaAPTIVUSBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- FinlandAptivusBoehringer Ingelheim International GmbH
- FranceAPTIVUS 250 mg, capsule molleBOEHRINGER INGELHEIM INTERNATIONAL
- IrelandAptivus 250 mg soft capsulesBoehringer Ingelheim International GmbH
- IcelandAptivusBoehringer Ingelheim International GmbH*
- PolandAptivusBoehringer Ingelheim International GmbH
- SwedenAptivus 250 mg Kapsel, mjukBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aptivus
- Liechtenstein · Aptivus
- Norway · Aptivus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08546b50-08a3-468d-9f3b-3f6a26bd516e GET /v1/drugs/08546b50-08a3-468d-9f3b-3f6a26bd516e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1130886000000}",
"nregistro": "05315001",
"substance": "tipranavir"
}See everything about tipranavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.